Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cutaneous sarcoidosis treated with levamisole.

N K Veien

    Dermatologica
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Levamisole treatment for cutaneous sarcoidosis showed limited efficacy. Only 2 of 13 patients experienced lesion clearance, with some experiencing disease worsening, indicating levamisole is not a beneficial treatment option.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    European evidence-based (S3) guidelines for the treatment of acne.

    Journal of the European Academy of Dermatology and Venereology : JEADV·2012
    Same author

    Clinical severity and prognosis of hand eczema.

    The British journal of dermatology·2009
    Same author

    Severity of hand eczema assessed by patients and dermatologist using a photographic guide.

    The British journal of dermatology·2007
    Same author

    Treatment of hand eczema.

    Skin therapy letter·2003
    Same author

    Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study.

    Acta dermato-venereologica·2002
    Same author

    Risk of developing subsequent nonmelanoma skin cancers.

    Archives of dermatology·2001

    Area of Science:

    • Dermatology
    • Immunology

    Background:

    • Cutaneous sarcoidosis is a chronic granulomatous disease affecting the skin.
    • Treatment options for cutaneous sarcoidosis can be limited, necessitating exploration of new therapeutic agents.

    Purpose of the Study:

    • To evaluate the efficacy and safety of levamisole in treating cutaneous sarcoidosis.

    Main Methods:

    • An open-label study involving 16 patients with cutaneous sarcoidosis.
    • Intermittent administration of levamisole over a 6-month period.
    • Assessment of skin lesion response and immunological parameters (tuberculin and dinitrochlorobenzene sensitivity).

    Main Results:

    • Skin lesions cleared in 2 out of 13 patients who completed the treatment.

    Related Experiment Videos

  • Two patients experienced an exacerbation of their sarcoidosis.
  • No increase in tuberculin sensitivity was observed.
  • Increased dinitrochlorobenzene sensitivity occurred in 5 patients, but without lesion improvement.

    • Conclusions:

    • Levamisole demonstrated limited therapeutic benefit in the treatment of cutaneous sarcoidosis.
    • The observed exacerbations and lack of significant lesion clearance suggest levamisole is not an effective treatment for this condition.